Abstract: Agrochemical formulation, comprising afidopyropen, a cypermethrin like alpha-cypermethrin, a) at least one organic solvent S, b) at least one alkanol substituted amine D, c) at least one aryl sulfonic acid E or their salts, d) at least one organic tricarboxylic acid F or their salts, e) at least one nonionic surfactant G different from components c) to f) and h), f) optionally further components.
Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
Type:
Grant
Filed:
January 18, 2023
Date of Patent:
January 7, 2025
Assignee:
Hope Medical Enterprises, Inc.
Inventors:
Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
Abstract: A method and system of improving efficacy of an insecticide, which includes attracting a target species to a treatment area using a synthetic trail pheromone, and exposing the target species to an insecticide at the treatment area.
Type:
Grant
Filed:
September 9, 2013
Date of Patent:
December 24, 2024
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Abstract: The disclosure provides methods and compositions for treating heart conditions. In particular, the disclosure provides compositions comprising lithium, or a salt thereof, either alone or in combination with at least one additional anti-arrhythmia agent, and methods for treating heart conditions using such compositions.
Abstract: The disclosure is directed to compositions and methods of increasing oxygen saturation (SpO2) in subjects in need thereof as well as alleviating, treating or curing symptoms and conditions associated with lower SpO2 levels (below 95%). The compositions are preferably solid and comprise a nitrate anion source, an elemental metal (uncharged), and optionally an acid. The compositions are preferably administered orally.
Abstract: A process for the preparation of a ready-to-use cosmetic, flowable cleaning agent, in which a powdered surfactant mixture is mixed with water in a specific weight ratio is described herein. A flowable cleaning agent obtainable by the process is also described.
Type:
Grant
Filed:
November 30, 2021
Date of Patent:
November 12, 2024
Assignee:
Henkel AG & Co. KGaA
Inventors:
Marlene Battermann, Sylvia Kerl, Heike Schelges, Sameh Hasan Fares
Abstract: The present invention relates to a nasal solution used for elimination of nasal occlusions, for cleaning of the inner section of the nose and for the treatment of nasal diseases, wherein bicarbonate (HCO3?) is provided with weight proportion between 0.05% and 1.50% and carbonate (CO3?2) is provided with weight proportion between 0.05% and 1.50% as the active substance in the ingredient thereof and it has alkali pH characteristic and preferably it is obtained from alkaline, closed basin natural spring waters.
Abstract: A fish-derived peptidoglycan recognition protein mutant and an application thereof are provided. An amino acid sequence of the mutant is shown in SEQ ID NO. 1, a nucleotide sequence of the mutant is shown in SEQ ID NO. 2. The present disclosure provides the preparation method for the mutant with a broad-spectrum antibacterial activity and robust inhibitory effects on both Gram-positive and Gram-negative bacteria. Compared with the wild-type LcPGRP5 protein, the mutant protein demonstrates a stronger ability to inhibit the activity against Staphylococcus aureus and enhance the phagocytic ability of fish macrophages.
Abstract: Compositions comprising nootkatone, benzyl benzoate and a carrier as well as methods for treating and preventing dust mite infestations are disclosed herein.
Abstract: Aspects of the disclosure relate to hair treatment compositions including about 0.1 to about 10 wt. % of a cationic surfactant; about 0.1 to about 10 wt. % of a fatty acid having a carbon chain of 12 or more carbons; about 0.1 to about 20 wt. % of a fatty alcohol; and about 50 wt. % or more of water, wherein all weight percentages are based on the total weight of the hair treatment composition. Additionally, the hair treatment compositions are formulated to have a molar ratio of the total amount of cationic surfactant to the total amount of fatty acid is about 1:0.8 to about 1:3 and a pH of about 2.5 to about 5.5. The disclosure also relates to methods for applying such hair treatment compositions.
Abstract: The present invention provides a permeable and options for semi-permeable inevitable substrate and substance made from minerals, vitamins, and detox formulas and is derived from the manufacturing process of the present invention. In one embodiment, the permeable inevitable substrate and substance may be used in clothing or other articles to be worn, in hospital settings, areas of nuclear waste, areas high in toxins, or areas of high radiation that may enable the radiation, the high energy levels and the toxins to activate the substrates and formulas that have been infused into clothing to self-clean and detox the clothing while it is being worn. In another embodiment, semi-permeable methods may be used by utilizing various forms of silicas and ortho silicates to ensure that positive molecules and ions are able to be diffused, while keeping out negative ions and minerals by diffusion or breaking apart the negative compositions.
Abstract: Compositions and methods regarding antimicrobial guanidinium macromolecules with one or more targeting moieties for selectively targeting bacteria are provided. According to an embodiment, an antimicrobial macromolecule is provided that comprises a polymer backbone and one or more guanidinium moieties that extend from the polymer backbone. The antimicrobial macromolecule further comprises a targeting moiety that extends from the polymer backbone. The targeting moiety can comprise a substance favored for consumption by bacteria, such as a monosaccharide.
Type:
Grant
Filed:
October 21, 2021
Date of Patent:
July 16, 2024
Assignees:
INTERNATIONAL BUSINESS MACHINES CORPORATION, AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
Inventors:
James L. Hedrick, Yi Yan Yang, Nathaniel H. Park, Victoria A. Piunova, Zhi Xiang Voo
Abstract: The present application provides compositions, methods, and systems for reducing allergic response to Fel D1. Such compositions, methods, and systems generally include a supplement comprising an anti-Fel D1 molecule and an animal digest.
Abstract: An insecticidal gel formulation including an insecticide active agent, sugar, sorbitol, hydrophilic fumed silica, xanthan gum, and a solvent is disclosed. Further, the insecticidal gel formulation comprises a total amount of hydrophilic fumed silica and xanthan gum of at least 3.6% by weight of the total insecticidal gel formulation.
Type:
Grant
Filed:
November 7, 2019
Date of Patent:
June 18, 2024
Assignee:
S. C. JOHNSON & SON, INC.
Inventors:
Pankaj Marwah, Maciej K. Tasz, Kevin Welzel
Abstract: The present invention pertains to the use of the calcium-sensing receptor (CaSR)-activating nutrients (designated as “CaSR-based nutrients”) for the prevention and/or treatment of diarrheal diseases and inflammation in the gastrointestinal tract. In one embodiment, the current invention is formulated for oral administration. The anti-diarrheal composition of the present invention is useful for treating diarrheal and gastrointestinal inflammatory conditions in infants and young children.
Type:
Grant
Filed:
December 14, 2020
Date of Patent:
May 21, 2024
Assignee:
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Abstract: A micronutrient composition shown as Mix 1 comprises Rosemary extract at 1 mg-6,000 mg, Fenugreek extract 1 mg-50,000 mg and Fenugreek seed powder at 2 mg-8,000 mg, Cassia nomane seed extract powder 1 mg to 1,000 mg and dry extract 1 mg-300 mg, 3?3-di indolylmethylene 1 mg-800 mg, Zinc 0.1 mg-1,000 mg, Phosphatidylserine 1 mg-1,500 mg, Vitamin D 20 IU-10,000 IU, Vitamin C 10 mg-50,000 mg, Niacin 1 mg-3,000 mg, Theanine 0.1 mg-10,000 mg, Aspartic acid 10 mg-10,000 mg, Arginine 10 mg-50,000 mg and Dehydroepiandrosterone (DHEA) 1 mg-500 mg and Mix A comprising of all the ingredients of Mix 1 but does not contain DHEA and both are used improve men's health.
Abstract: The invention relates to three-part makeup remover compositions comprising (a) a water part; (b) an oil part; and (c) a silicone-in-water emulsion part.
Abstract: Various embodiments of the invention relate to compositions comprising vitamins, minerals and trace elements, antioxidants, amino acids, probiotics, and other components and methods for using such compositions to treat or prevent diseases associated with oxidative stress, including cardiovascular disease.
Abstract: A hair conditioner composition containing an aqueous carrier, from about 2.5 wt % to about 6.7 wt % of a behenamidopropyl dimethylamine, from about 3 wt % to about 8 wt % of a fatty alcohol; and less than 1.5 wt % of a salt. The molar ratio of behenamidopropyl dimethylamine to fatty alcohol can be from about 7:50 to about 4:5. The conditioner composition can have a uniform gel network. The composition can have d-spacing of less than 32 nm, as measured according to the d-spacing (L?-basal spacing) of Lamella Gel Network Test Method.
Type:
Grant
Filed:
December 1, 2020
Date of Patent:
April 16, 2024
Assignee:
The Procter & Gamble Company
Inventors:
Jean Jianqun Zhao, Lauren Elizabeth Ballhaus, Heather Lynn Focht, David Joseph Kaufman, Christina Marie McQueen, Deborah Mulligan, Lina Aurora Witte
Abstract: A topical composition and method of treating chronic pain are provided. The topical composition contains cannabidiol (CBD) and plant extract and is well suited to treat chronic pain while also avoiding the negative side effects caused by commonly used anti-inflammatory and pain-treating compounds. When the topical composition is applied to the skin at the locus of pain and allowed sufficient time to absorb, the pain is reduced or even eliminated. The topical compositions also show therapeutic effect on mucosal tissue and internal tissues of humans or animals.